Cancer Family
Lung Neoplasm
CI-CAN-00000221Explore in graph →
Non-malignant2,726 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000221Explore in graph →
Clinical trials
11,603 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01784549 | Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease(CONTEST) | unknown | Phase 2 | 168 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT02272127 | Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer | unknown | Phase 2 | 100 | Nanfang Hospital, Southern Medical University |
| 1 |
| Oct 22, 2014 |
| clinicaltrials |
| NCT02262897 | The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT01624051 | A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer | unknown | Phase 2 | 144 | AHS Cancer Control AlbertaOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT01424709 | Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)(BRAVO) | unknown | Phase 2 | 120 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT02224547 | Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System | unknown | Phase 2 | 58 | Universitair Ziekenhuis BrusselOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT02215356 | Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT02191059 | Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer | unknown | Phase 2 | 60 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT02146118 | A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 2 | 42 | MedicalLogicINDUSTRY | 1 | May 23, 2014 | clinicaltrials |
| NCT02139579 | Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer | unknown | Phase 2 | 24 | Sun Yat-sen UniversityOTHER | 0 | May 15, 2014 | clinicaltrials |
| NCT02133677 | A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases | unknown | Phase 2 | 24 | Far Eastern Memorial HospitalOTHER | 1 | May 8, 2014 | clinicaltrials |
| NCT01969955 | Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01861223 | Afatinib Plus Nimotuzumb for NSCLC | unknown | Phase 1 / Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02066038 | Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 0 | Feb 19, 2014 | clinicaltrials |
| NCT02039518 | Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients | unknown | Phase 2 | 160 | Fudan UniversityOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT02036359 | Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca(Oncology) | unknown | Phase 2 | 76 | National Taiwan University HospitalOTHER | 1 | Jan 15, 2014 | clinicaltrials |
| NCT00514293 | Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 39 | Raghu Nandan, M.D., IncOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00003284 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | unknown | Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00022243 | T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy | unknown | Phase 2 | — | TularikINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00030641 | Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | Genta IncorporatedINDUSTRY | 3 | Jan 6, 2014 | clinicaltrials |
| NCT00033722 | Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | TularikINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT01998061 | Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression | unknown | Phase 2 | 20 | Zhejiang UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT02005120 | Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC | unknown | Phase 2 | 20 | Zhejiang UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00006215 | Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00021008 | ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00278187 | Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016209 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer | unknown | Phase 2 | 30 | Zhejiang UniversityOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004253 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 | — | Baptist Health South FloridaOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00005825 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 2 | — | Raghu Nandan, M.D., IncOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00052325 | Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy | unknown | Phase 2 | — | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00809237 | Hydroxychloroquine and Gefitinib to Treat Lung Cancer | unknown | Phase 1 / Phase 2 | 71 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01347424 | Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2013 | clinicaltrials |
| NCT00003562 | Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 2 | 38 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003583 | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | unknown | Phase 2 | 20 | University of FloridaOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00004264 | Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00004265 | Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer | unknown | Phase 2 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01027676 | Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC) | unknown | Phase 1 / Phase 2 | 50 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 14, 2013 | clinicaltrials |
| NCT00003090 | Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer | unknown | Phase 2 | 30 | Cancer Biotherapy Research GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00104780 | Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | unknown | Phase 2 | — | EpimmuneINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01533233 | Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients | unknown | Phase 1 / Phase 2 | 100 | National Taiwan University HospitalOTHER | 1 | Oct 29, 2013 | clinicaltrials |
| NCT00022009 | Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01932229 | An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib | unknown | Phase 2 | 20 | Sheba Medical CenterOTHER_GOV | 1 | Aug 30, 2013 | clinicaltrials |
| NCT01926483 | Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection(ZTOG-1202) | unknown | Phase 2 | 75 | Zhejiang Cancer HospitalOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT00398385 | Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer | unknown | Phase 2 | 170 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00616031 | Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 150 | Kyoto UniversityOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01024712 | Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 26 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01914458 | Image Discovering Early Lung Cancer Project(IDEALCAP) | unknown | Phase 2 | 600 | Cathay General HospitalOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01881516 | Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF） | unknown | Phase 2 | 32 | Fudan UniversityOTHER | 0 | Jun 19, 2013 | clinicaltrials |
| NCT01872416 | A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT01872403 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung | unknown | Phase 2 | 120 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 7, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Nov 25, 2014source: clinicaltrials